LIS Technologies, an Oak Ridge, TN-based proprietary developer of advanced laser technology, closed its expanded $11.88M Seed funding.
The round included participation from 28 Ventures Fund, an advanced USA nuclear technology company, and active nuclear technology investors.
The company intends to use the funds to advance the build-out of a new facility in Oak Ridge for physical test work and demonstrations, and to hire additional talent for its existing team of scientists and engineers.
Led by CEO Christo Liebenberg, LIS Technologies is a proprietary developer of patented advanced laser technology, making use of infrared wavelengths to selectively excite the molecules of desired isotopes to separate them from other isotopes. The Laser Isotope Separation Technology (L.I.S.T) has a huge range of applications, including being the only USA-origin (and patented) laser uranium enrichment company, and advantages over traditional methods such as gas diffusion, centrifuges, and prior art laser enrichment. L.I.S.T is optimized for LEU (Low Enriched Uranium) for existing civilian nuclear power plants, High-Assay LEU (HALEU) for the next generation of Small Modular Reactors (SMR) and Microreactors, the production of stable isotopes for medical and scientific research, and applications in quantum computing manufacturing for semiconductor technologies.
The company employs a nuclear technical team working alongside nuclear entrepreneurs and industry professionals, possessing relationships with government and private nuclear industries.